Myriad Genetics, Inc.
MYGN
$10.18
-$0.34-3.23%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 102.40M | 99.90M | 97.30M | 104.30M | 140.90M |
| Total Receivables | 121.20M | 125.70M | 117.80M | 118.10M | 114.30M |
| Inventory | 27.50M | 26.20M | 26.10M | 24.60M | 22.00M |
| Prepaid Expenses | 38.30M | 41.40M | 40.00M | 43.30M | 35.20M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 8.60M | -- | 10.40M | -- | 1.20M |
| Total Current Assets | 298.00M | 293.20M | 291.60M | 290.30M | 313.60M |
|
|
|||||
| Total Current Assets | 298.00M | 293.20M | 291.60M | 290.30M | 313.60M |
| Net Property, Plant & Equipment | 172.40M | 172.80M | 172.80M | 177.40M | 180.60M |
| Long-term Investments | 286.30M | 286.30M | 286.30M | 287.00M | 287.40M |
| Goodwill | 286.30M | 286.30M | 286.30M | 287.00M | 287.40M |
| Total Other Intangibles | 265.80M | 312.50M | 319.50M | 340.90M | 354.10M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.10M | 16.50M | 14.90M | 14.90M | 10.80M |
| Total Assets | 1.03B | 1.08B | 1.09B | 1.11B | 1.15B |
|
|
|||||
| Total Accounts Payable | 32.30M | 29.60M | 33.30M | 33.10M | 25.80M |
| Total Accrued Expenses | 79.90M | 77.50M | 98.30M | 60.60M | 75.70M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 12.80M | 13.50M | 13.30M | 13.80M | 16.20M |
| Total Finance Division Other Current Liabilities | 39.10M | 33.70M | 4.00M | 38.60M | 38.20M |
| Total Other Current Liabilities | 39.10M | 33.70M | 4.00M | 38.60M | 38.20M |
| Total Current Liabilities | 164.10M | 154.30M | 148.90M | 146.10M | 155.90M |
|
|
|||||
| Total Current Liabilities | 164.10M | 154.30M | 148.90M | 146.10M | 155.90M |
| Long-Term Debt | 39.60M | 39.00M | 38.80M | 38.70M | 38.50M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 87.90M | 90.60M | 91.20M | 94.30M | 97.40M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 34.90M | 65.70M | 65.70M | 71.40M | 71.50M |
| Total Liabilities | 326.50M | 349.60M | 344.60M | 350.50M | 363.30M |
|
|
|||||
| Common Stock & APIC | 1.46B | 1.45B | 1.44B | 1.42B | 1.42B |
| Retained Earnings | -756.80M | -714.30M | -692.20M | -655.50M | -629.50M |
| Treasury Stock & Other | -800.00K | -100.00K | -4.00M | -4.20M | -3.70M |
| Total Common Equity | 701.10M | 731.70M | 740.50M | 760.00M | 783.20M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 701.10M | 731.70M | 740.50M | 760.00M | 783.20M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 701.10M | 731.70M | 740.50M | 760.00M | 783.20M |
|
|
|||||
